# GSK2018682 FTIH in Healthy Volunteers

> **NCT01387217** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 27 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** GSK2018682
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01387217
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05-21
- **Primary completion:** 2010-12-20
- **Final completion:** 2010-12-20
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2017-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01387217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01387217, "GSK2018682 FTIH in Healthy Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01387217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*